These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 30056000

  • 1. Thrombolysis with rt-PA under Rivaroxaban Anticoagulation in a Hypertensive Rat Model of Intraluminal Middle Cerebral Artery Occlusion.
    Izuma H, Oka F, Ishihara H, Inoue T, Suehiro E, Nomura S, Suzuki M.
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2761-2767. PubMed ID: 30056000
    [Abstract] [Full Text] [Related]

  • 2. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with rivaroxaban.
    Ishihara H, Torii H, Imoto H, Oka F, Sadahiro H, Suzuki M.
    J Stroke Cerebrovasc Dis; 2014 Oct; 23(10):e457-e459. PubMed ID: 25280819
    [Abstract] [Full Text] [Related]

  • 3. Rivaroxaban and apixaban reduce hemorrhagic transformation after thrombolysis by protection of neurovascular unit in rat.
    Kono S, Yamashita T, Deguchi K, Omote Y, Yunoki T, Sato K, Kurata T, Hishikawa N, Abe K.
    Stroke; 2014 Aug; 45(8):2404-10. PubMed ID: 24984746
    [Abstract] [Full Text] [Related]

  • 4. Involvement of thrombolysis in recombinant tissue plasminogen activator-induced cerebral hemorrhages and effect on infarct volume and postischemic endothelial function.
    Gautier S, Petrault O, Gele P, Laprais M, Bastide M, Bauters A, Deplanque D, Jude B, Caron J, Bordet R.
    Stroke; 2003 Dec; 34(12):2975-9. PubMed ID: 14615621
    [Abstract] [Full Text] [Related]

  • 5. The role of connexin43 in hemorrhagic transformation after thrombolysis in vivo and in vitro.
    Yang X, Chu H, Tang Y, Dong Q.
    Neuroscience; 2016 Aug 04; 329():54-65. PubMed ID: 27138645
    [Abstract] [Full Text] [Related]

  • 6. TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats.
    Cai Y, Liu X, Chen W, Wang Z, Xu G, Zeng Y, Ma Y.
    Exp Neurol; 2015 Apr 04; 266():120-6. PubMed ID: 25708985
    [Abstract] [Full Text] [Related]

  • 7. Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats.
    Copin JC, Gasche Y.
    Brain Res; 2008 Dec 03; 1243():161-6. PubMed ID: 18835259
    [Abstract] [Full Text] [Related]

  • 8. tPA Mobilizes Immune Cells That Exacerbate Hemorrhagic Transformation in Stroke.
    Shi K, Zou M, Jia DM, Shi S, Yang X, Liu Q, Dong JF, Sheth KN, Wang X, Shi FD.
    Circ Res; 2021 Jan 08; 128(1):62-75. PubMed ID: 33070717
    [Abstract] [Full Text] [Related]

  • 9. Hemorrhagic transformation during thrombolytic therapy and reperfusion: effects of age, blood pressure, and matrix metalloproteinases.
    Lyden PD.
    J Stroke Cerebrovasc Dis; 2013 May 08; 22(4):532-8. PubMed ID: 23453556
    [Abstract] [Full Text] [Related]

  • 10. Reperfusion-associated hemorrhagic transformation in SHR rats: evidence of symptomatic parenchymal hematoma.
    Henning EC, Latour LL, Hallenbeck JM, Warach S.
    Stroke; 2008 Dec 08; 39(12):3405-10. PubMed ID: 18757286
    [Abstract] [Full Text] [Related]

  • 11. Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience.
    Aronowski J, Strong R, Shirzadi A, Grotta JC.
    Stroke; 2003 May 08; 34(5):1246-51. PubMed ID: 12690223
    [Abstract] [Full Text] [Related]

  • 12. Safety of low-frequency transcranial ultrasound in permanent middle cerebral artery occlusion in spontaneously hypertensive rats.
    Wang Z, Fukuda T, Azuma T, Furuhata H.
    Cerebrovasc Dis; 2012 May 08; 33(1):23-9. PubMed ID: 22133698
    [Abstract] [Full Text] [Related]

  • 13. Safety of early initiation of rivaroxaban or dabigatran after thrombolysis in acute ischemic stroke.
    Ritzenthaler T, Derex L, Davenas C, Bnouhanna W, Farghali A, Mechtouff L, Cho TH, Nighoghossian N.
    Rev Neurol (Paris); 2015 Sep 08; 171(8-9):613-5. PubMed ID: 25857461
    [Abstract] [Full Text] [Related]

  • 14. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.
    Allahtavakoli M, Amin F, Esmaeeli-Nadimi A, Shamsizadeh A, Kazemi-Arababadi M, Kennedy D.
    Basic Clin Pharmacol Toxicol; 2015 Nov 08; 117(5):335-9. PubMed ID: 25899606
    [Abstract] [Full Text] [Related]

  • 15. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis.
    Reinhard M, Wihler C, Roth M, Harloff A, Niesen WD, Timmer J, Weiller C, Hetzel A.
    Cerebrovasc Dis; 2008 Nov 08; 26(2):147-55. PubMed ID: 18560218
    [Abstract] [Full Text] [Related]

  • 16. Effects of a TAFI-inhibitor combined with a suboptimal dose of rtPA in a murine thromboembolic model of stroke.
    Durand A, Chauveau F, Cho TH, Kallus C, Wagner M, Boutitie F, Maucort-Boulch D, Berthezène Y, Wiart M, Nighoghossian N.
    Cerebrovasc Dis; 2014 Nov 08; 38(4):268-75. PubMed ID: 25401979
    [Abstract] [Full Text] [Related]

  • 17. Reduction of intracerebral hemorrhage by rivaroxaban after tPA thrombolysis is associated with downregulation of PAR-1 and PAR-2.
    Morihara R, Yamashita T, Kono S, Shang J, Nakano Y, Sato K, Hishikawa N, Ohta Y, Heitmeier S, Perzborn E, Abe K.
    J Neurosci Res; 2017 Sep 08; 95(9):1818-1828. PubMed ID: 28035779
    [Abstract] [Full Text] [Related]

  • 18. Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model.
    Dijkhuizen RM, Asahi M, Wu O, Rosen BR, Lo EH.
    Stroke; 2002 Aug 08; 33(8):2100-4. PubMed ID: 12154270
    [Abstract] [Full Text] [Related]

  • 19. Brain hemorrhages after rt-PA treatment of embolic stroke in spontaneously hypertensive rats.
    Brinker G, Pillekamp F, Hossmann KA.
    Neuroreport; 1999 Jun 23; 10(9):1943-6. PubMed ID: 10501537
    [Abstract] [Full Text] [Related]

  • 20. Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.
    Pfeilschifter W, Bohmann F, Baumgarten P, Mittelbronn M, Pfeilschifter J, Lindhoff-Last E, Steinmetz H, Foerch C.
    Ann Neurol; 2012 May 23; 71(5):624-33. PubMed ID: 22447744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.